Journal List > J Korean Soc Hypertens > v.17(1) > 1089777

TOOLS
Choi, Park, Oh, and Baek: Effects of Angiotensin II and Shear Stress Interaction on Vascular Inflammation
Original Article

J Korean Soc Hypertens 2011;17(1):17-27.

Published online: 10 March 2011

DOI: https://doi.org/10.5646/jksh.2011.17.1.17

Effects of Angiotensin II and Shear Stress Interaction on Vascular Inflammation

Sung Hyun Choi, MS1, Eun Hye Park, MS1, Yujin Oh, BSc3, Sang Hong Baek, MD1, 2,

1Laboratory of Cardiovascular Research, The Catholic University of Korea School of Medicine, Seoul, Korea

2Division of Cardiovascular Medicine, St. Seoul Mary’s Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea

3Department Biology, University of Miami College of Arts and Sciences, Coral Gables, FL, USA

Tel: 02) 2258-6030, Fax: 02) 591-1506 E-mail: whitesh@catholic.ac.kr

Received 20 December 201031 December 2010       Accepted 3 January 2011

Copyright © 2011 The Korean Society of Hypertension

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ABSTRACT

Background:

Angiotensin II (AngII) and abnormal oscillatory shear stress are highly associated with vascular inflammation including atherosclerosis. However, it is poorly understood how interactions between AngII and shear stress in human aortic endothelial cells (HAEC) are involved in mechanisms by which cellular adhesion molecules are expressed. The purpose of this study was to improve that understanding.

Methods:

AngII (10-7M for 6 hr) and two-types of shear stress treatments were used: laminar shear stress (LS: unidirectional, 12 dynes/cm2) and oscillatory shear stress (OS: bi-directional, 5 dynes/cm2, 1 Hz) in HAEC. Immunoblotting was used to detect expression of cellular adhesion molecules markers such as vascular cell adhesion molecule 1 (VCAM1) and intercellular adhesion molecule 1 (ICAM1).

Results:

AngII significantly increased VCAM1 and ICAM1 expression in HAEC that had been reduced due to pretreatment with telmisartan. AngII-LS co-stimulation and AngII-OS co-stimulation significantly increased VCAM1 and ICAM1 expression in HAEC. The expression levels of VCAM1 and ICAM1 were also, significantly reduced when pretreated with telmisartan. However, VCAM1 and ICAM1 expression were significantly reduced under LS and OS stimulation.

Conclusions:

Telmisartan may modulate the expressions of VCAM1 and ICAM1 via different types of shear stress in HAEC that are activated by AngII.

Keywords: Vascular cell adhesion molecule 1, Intercellular adhesion molecule 1, Angiotensin II, Shear stress, Human aortic endothelial cell

References

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105:1135–43.
crossref
2. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994; 74:1141–8.
crossref
3. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001; 37:1053–9.
4. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L, Williams B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res. 2008; 102:201–8.
crossref
5. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J. 2003; 79:195–9.
crossref
6. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993; 171:223–9.
crossref
7. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol. 1998; 18:842–51.
crossref
8. Ando J, Tsuboi H, Korenaga R, Takada Y, Toyama-Sorimachi N, Miyasaka M, et al. Shear stress inhibits adhesion of cultured mouse endothelial cells to lymphocytes by downregulating VCAM-1 expression. Am J Physiol. 1994; 267:C679–87.
crossref
9. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA. 1999; 282:2035–42.
crossref
10. Catt KJ, Mendelsohn FA, Millan MA, Aguilera G. The role of angiotensin II receptors in vascular regulation. J Cardiovasc Pharmacol. 1984; 6(Suppl 4):S575–86.
crossref
11. Hitomi H, Kiyomoto H, Nishiyama A. Angiotensin II and oxidative stress. Curr Opin Cardiol. 2007; 22:311–5.
crossref
12. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci. 2008; 29:367–74.
crossref
13. Choi SH, Park EH, Sim CE, Baek SH. Effects of angiotensin II receptor blockers on endothelial progenitor cells in spontaneously hypertensive rats. J Korean Soc Hypertens. 2009; 15:42–50.
14. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol. 2000; 20:645–51.
15. Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation. 1999; 100:1223–9.
16. Walpola PL, Gotlieb AI, Cybulsky MI, Langille BL. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress. Arterioscler Thromb Vasc Biol. 1995; 15:2–10.
crossref
17. Weiss D, Sorescu D, Taylor WR. Angiotensin II and atherosclerosis. Am J Cardiol. 2001; 87(Suppl):25C–32C.
crossref
18. Cunningham KS, Gotlieb AI. The role of shear stress in the pathogenesis of atherosclerosis. Lab Invest. 2005; 85:9–23.
crossref
19. Go YM, Boo YC, Park H, Maland MC, Patel R. Pritchard KA Jr, et al. Protein kinase B/Akt activates c-Jun NH(2)-terminal kinase by increasing NO production in response to shear stress. J Appl Physiol. 2001; 91:1574–81.
20. Sorescu GP, Sykes M, Weiss D, Platt MO, Saha A, Hwang J, et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem. 2003; 278:31128–35.
crossref
21. Schmidt-Ott KM, Kagiyama S, Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept. 2000; 93:65–77.
crossref
22. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 1995; 91:2488–96.
23. Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999; 340:115–26.
24. Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation. 2002; 106:820–5.
crossref
25. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Domi-niczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens. 2001; 10:247–55.
crossref
26. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II-mediated hyper-tension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest. 1996; 97:1916–23.
crossref
27. Abe J, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med. 1998; 8:59–64.
crossref
28. Charles RL, Eaton P. Redox signalling in cardiovascular disease. Proteomics Clin Appl. 2008; 2:823–36.
crossref
29. Fukuda D, Enomoto S, Hirata Y, Nagai R, Sata M. The angiotensin receptor blocker, telmisartan, reduces and stabilizes atherosclerosis in ApoE and AT1aR double deficient mice. Biomed Pharmacother. 2010; 64:712–7.
crossref
30. An J, Nakajima T, Kuba K, Kimura A. Losartan inhibits LPS-induced inflammatory signaling through a PPARgamma-dependent mechanism in human THP-1 macrophages. Hypertens Res. 2010; 33:831–5.
31. Yao R, Cheng X, Chen Y, Xie JJ, Yu X, Liao MY, et al. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice. Int J Cardiol. 2010; 139:113–22.
32. O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993; 92:945–51.
33. O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 1996; 93:672–82.
crossref
34. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998; 18:677–85.
35. Chiu JJ, Lee PL, Chen CN, Lee CI, Chang SF, Chen LJ, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler Thromb Vasc Biol. 2004; 24:73–9.
36. Sucosky P, Balachandran K, Elhammali A, Jo H, Yoganathan AP. Altered shear stress stimulates upregu-lation of endothelial VCAM-1 and ICAM-1 in a BMP-4-and TGF-beta1-dependent pathway. Arterioscler Thromb Vasc Biol. 2009; 29:254–60.
37. Mohan S, Mohan N, Valente AJ, Sprague EA. Regulation of low shear flow-induced HAEC VCAM-1 expression and monocyte adhesion. Am J Physiol. 1999; 276:C1100–7.
crossref
38. Lan Q, Mercurius KO, Davies PF. Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress. Biochem Biophys Res Commun. 1994; 201:950–6.
39. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994; 12:141–79.

Fig. 1.
MTS (HAEC viability) assay. HAEC viability was significantly decreased in 10-6M AngII treated group as compared to the control. OD (optical density) ratio. AngII was incubated for 18 hours with EBM-2. *p<0.01 compared to the control. Data were obtained in at least 3 independent experiments, obtained with different sets of cells. MTS, 3-(4,5-demethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-Sulfopheynyl)-2H-tetrazolium; HAEC, human aortic endothelial cells.
jksh-17-17f1.tif
Fig. 2.
Analysis of VCAM1 expression according to different concentrations of AngII. The expression of VCAM1 was measured by western blot (A), and quantitative results that normalized with actin are shown (B). AngII was incubated for 18 hours with EBM-2. Data were obtained in at least 3 independent experiments, obtained with different sets of cells. VCAM1, vascular cell adhesion molecule 1; AngII, angiotensin II.
jksh-17-17f2.tif
Fig. 3.
Analysis of the VCAM1 expression according to different exposure durations of Ang II. The expression of VCAM1 was measured by western blot (A) and quantitative results that normalized by actin are shown (B). AngII treated concentration was 10-7M cotreated with EBM-2. Data were obtained in at least 3 independent experiments, obtained with different sets of cells. VCAM1, vascular cell adhesion molecule 1; AngII, angiotensin II.
jksh-17-17f3.tif
Fig. 4.
Analysis of the VCAM1 and ICAM1 expression after AngII with and without pre-treatment of ARB (telmisartan). The expression of VCAM1 and ICAM1 was analyzed by western blot (A), and quantitative results that normalized by actin are shown (B, C). VCAM1 and ICAM1 expressions were increased by treatment with AngII as compared to the control, and their expression was significantly reduced after pre-treatment of ARB. The degree of reduction in ICAM1 was larger than VCAM1. AngII: 10-7M, for 18 hours in EBM-2, ARB: telmisartan, 10-7M, for 30 minutes before treatment with AngII in EBM-2. Data were obtained in at least 3 independent experiments, obtained with different sets of cells. VCAM1, vascular cell adhesion molecule 1; AngII, angiotensin II.
jksh-17-17f4.tif
Fig. 5.
Representative HAEC morphology after laminar shear stress and oscillatory shear stress. Cell morphologyunder light microscopy of the control group (A), treatment with unidirectional laminar shear stress (12 dynes/cm2) in HAEC (B), and treatment with bidirectional oscillatory shear stress (5 dynes/cm2, 1 Hz) in HAEC (C). Shear stresses were treated for 18 to 19 hours. HAEC, human aortic endothelial cells.
jksh-17-17f5.tif
Fig. 6.
Analysis of VCAM1 and ICAM1 expressions by interaction between laminar shear stress (LS) and Ang II. The expression levels of VCAM1 and ICAM1 were detected by western blot (A), and quantitative result that normalized by actin are shown (B). LS or LS and AngII costimulation increased VCAM1 and ICAM1 expression levels as compared to the control. VCAM1 expression was significantly reduced by pre-treatment of ARB. LS (force: 12 dynes/cm2, incubation times: 18 hr), AngII (concentration: 10-7M, incubation times: 6hr), ARB (telmisartan, concentration: 10-7M, incubation times: 30 min). *p<0.01, compared to control, **p<0.05, compared to control, † p< 0.01, compared to LS group. Data were obtainedin at least 3 independent experiments, obtained with different sets of cells. VCAM1, vascular cell adhesion molecule 1; ICAM1, intercellular adhesion molecule 1; AngII, angiotensin II.
jksh-17-17f6.tif
Fig. 7.
Analysis of VCAM1 and ICAM1 expressions by interaction between oscillatory shear stress (OS) and Ang II. The expression levels of VCAM1 and ICAM1 were detected by western blot (A) and quantitative result that normalized by actin are shown (B) OS or OS and AngII costimulation increased VCAM1 and ICAM1 expression levels as compared to the control. ICAM1 expression was significantly reduced by pre-treatment of ARB. LS (force: 12 dynes/cm2, incubation times: 18 hr), AngII (concentration: 10-7M, incubation times: 6hr), ARB (telmisartan, concentration: 10-7M, incubation times: 30 min). *p<0.01, compared to control, **p<0.05, compared to control, †p<0.01, compared to LS group. VCAM1, vascular cell adhesion molecule 1; ICAM1, intercellular adhesion molecule 1; LS, laminar shear stress.
jksh-17-17f7.tif
Table 1.
The expression levels of VCAM1 and ICAM1 in LS and OS treatment groups as compared to control group
Compared with Control Group (%)
LS OS
- Ang II TERT TERT+Ang II - Ang II TERT TERT+Ang II
VCAM1 +168.5 +126.2 NS NS +132.1 +67.9 +153.2 +178.8
ICAM1 +51.1 +207.8 +221.8 +361.6 +620.1 +537.9 +753.6 +352.5

LS, lanimar shear stress; OS, oscillatory shear stress; Ang II, angiotensin II; TERT, telmisartan; NS, not significant. VCAM, vascular cell adhesion molecule 1; ICAM1, intercellular adhesion molecule 1.

Table 2.
The expression levels of VCAM1 and ICAM1 in LS and OS treatment groups as compared to each groups control (LS only and OS only)
Compared with control group (%)
LS OS
Ang II TERT TERT+Ang II Ang II TERT TERT+Ang II
VCAM1 NS -56.6 -60.4 -27.7 NS NS
ICAM1 +103.7 +112.9 +205.5 NS NS -37.1

LS, lanimar shear stress; OS, oscillatory shear stress; Ang II, angiotensin II; TERT, telmisartan; NS, not significant. VCAM, vascular cell adhesion molecule 1; ICAM1, intercellular adhesion molecule 1.

TOOLS
Similar articles